Intense Therapeutic Ultrasound for the Treatment of Chronic Plantar Fasciitis
CompletedNot applicableNCT03254602
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
A clinical trial evaluating the effectiveness, safety and patient tolerance for the use of Intense Therapeutic Ultrasound (ITU) for chronic, Plantar Fasciitis musculoskeletal tissue pain reduction began in August 2016 and was completed in April 2017. The clinical setting: University Foot and Ankle Institute, Santa Monica, California, USA; Single-Blinded, pivotal study for chronic plantar fasciitis.
Study details
- Official title
- Intense Therapeutic Ultrasound for the Treatment of Chronic Plantar Fasciitis Musculoskeletal Pain Reduction
- Conditions
- Interventions
- Device: Intense Therapeutic Ultrasound Treatment
- Sponsor
- University Foot and Ankle Foundation
- Collaborators
- Guided Therapy Systems
- Start date
- 2016-08-04
- Primary completion
- 2017-04-10
- Sex
- All
- Age range
- from 18 Years to 85 Years
- Healthy volunteers
- true
- Results posted
- Yes, on ClinicalTrials.gov
- Total sites listed
- 0
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Chronic Pain (\>90 days) from previously diagnosed Plantar Fasciitis, where "Standard of Care" regimens failed to relief pain in the affected anatomy. * No History of surgery to the affected anatomy. * No alternative treatment procedures within the last 90 days. * Age: 18 - 85, depending on the study. * Unilateral Pain * Willingness to complete treatment and post treatment regimen as described. * Patients who have provided written and verbal informed consent. Exclusion Criteria: * Patients currently enrolled in any other non-conservative, device, or Investigational New Drug clinical trial, or who have participated in a clinical study involving the Plantar Fascia, thirty days prior to study initiation; * Patients who have participated in any other clinical study involving an investigational product 30 days prior to enrollment that, in the opinion of the Principal Investigator, could affect the outcome of this study; * Patients who have received previous treatment in the symptomatic limb (not including conservative treatment); * At the Principal Investigator's discretion, any patient that should be excluded based on their current condition or medical history.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03254602